Globally, the obesity surgery devices market is witnessing significant growth due to increasing obesity epidemic and increasing sedentary lifestyle and junk food habits. Increasing prevalence of obesity among children and adults is posing a threat in both developed and developing nations. Excess body weight directly contributes to increasing risk of stroke, heart diseases, type-2 diabetes and some forms of cancer. Obesity surgery is a broadly available treatment for persons with severe and complex obesity. However, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable. In addition, selective nature of obesity surgery, due to its complications, restricts growth of obesity surgery devices market.
Request Sample Copy of the Report @ http://www.mrrse.com/sample/450
The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.
North America is the largest market for global obesity surgery devices. Roux-en-Y gastric bypass is the largest procedure of obesity surgery and staples is the largest type of obesity surgery device. In terms of growth, Asia Pacific is the fastest growing region, sleeve gastrectomy is the fastest growing procedure and gastric electrical stimulation is the fastest growing type of obesity surgery device.
Enquiry For This Report @ http://www.mrrse.com/enquiry/450
North America obesity surgery devices market was valued at USD 968.7 million in 2014 and is expected to reach USD 1,665.2 million in 2020, growing at a CAGR of 9.4% from 2014 to 2020.
Roux-en-Y gastric bypass procedure for obesity surgery was valued at USD 691.4 million in 2014 and is expected to reach USD 1,225.9 million in 2020, growing at a CAGR of 10% from 2014 to 2020.
Read Complete Report with TOC @ http://www.mrrse.com/obesity-surgery-devices-market
90 State Street, Suite 700
Albany, NY 12207United States